Evaluation of B cell maturation antigen as a target for antibody drug conjugate mediated cytotoxicity in multiple myeloma

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2141|174|6|911-922

ISSN： 0007-1048

Source： BRITISH JOURNAL OF HAEMATOLOGY, Vol.174, Iss.6, 2016-09, pp. : 911-922

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Romidepsin Overcomes Cell Adhesion-Mediated Drug Resistance in Multiple Myeloma Cells

By  

Acta Haematologica, Vol. 132, Iss. 1, 2013-12 ,pp. : 1-4

Karger

Access to resources Recommend Favorite

MDX‐1097 induces antibody‐dependent cellular cytotoxicity against kappa multiple myeloma cells and its activity is augmented by lenalidomide

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 169, Iss. 3, 2015-05 ,pp. : 333-343

John Wiley & Sons Inc

Access to resources Recommend Favorite

An Fc Double-Engineered CD20 Antibody with Enhanced Ability to Trigger Complement-Dependent Cytotoxicity and Antibody-Dependent Cell-Mediated Cytotoxicity

By  

Transfusion Medicine and Hemotherapy, Vol. 44, Iss. 5, 2017-09 ,pp. : 292-300

Karger

Access to resources Recommend Favorite

Evaluation of the spectra Optia® mononuclear cell collection procedure in multiple myeloma patients

By  

JOURNAL OF CLINICAL APHERESIS, Vol. 30, Iss. 1, 2015-02 ,pp. : 1-7

John Wiley & Sons Inc

Access to resources Recommend Favorite

Interleukin-6-Mediated Cell Growth in Multiple Myeloma – a Role for Viscum album Extracts?

By  

Oncology Research and Treatment, Vol. 28, Iss. 8-9, 2005-08 ,pp. : 387-387

Karger

Access to resources Recommend Favorite